The stratum corneum (SC) forms the outermost layer of the human skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment membrane integrity and significantly increase membrane tortuosity. The lipophilic character of the SC, coupled with its intrinsic tortuosity, ensure that it almost always provides the principal barrier to the entry of drug molecules into the organism. Drugs can be administered either as suspensions or as solutions and the formulation can range in complexity from a gel or and ointment to a multilayer transdermal path. In this paper, we discuss theoretical principles used to describe transdermal release and we show that relatively simple membrane transport models based on the appropriate solution to the Fick's second law of diffusion can be used to explain drug release kinetics into such a complex biological membrane as the human skin. To apply the Fick's law we introduced into our considerations a brick-and-mortar model with two factors of tortuosity. Assuming that the mortar thickness is variable we also introduced the hindrance factor allowing us to model this variability. Having the modified Fick's equation we presented its general solution and two special cases of this solution frequently applicable in permeation experiments. It seems that the solutions presented herein better approximate the real conditions of drug delivery then these well known.
Introduction
Fluid flow and diffusion transport within natural tissues play an important role in morphogenesis, metabolism functions and pathogenesis. In the design of new biomaterials mimicking biological tissues, it is well recognized today that a three-dimensional "in vitro" culture better recapitulates physiological cell environment. Fluid flow and solid strain that are imposed within tissue not only affect cell nourishment but also exert on cell mechanical actions such as pressure effects, drag interactions and viscous shear stresses.
Every cell is distinguished from its environment by means of a semipermeable membrane. This membrane plays a crucial role in the ability of the cell to function; the loss of membrane integrity, except for brief periods, would almost certainly lead to the cell's death. This paper addresses modelling and treatment of mass transport through biological tissues, specially the skin, considered as a porous medium; the mass transport is narrowed down to the diffusion in the skin drug delivery.
The skin drug delivery can be subdivided into topical and transdermal. In a topical delivery the drug is intended to act at skin level, this is indicated for the treatment of skin diseases.
The outer skin layer, the epidermis, is without vasculature and acts as a protective barrier preventing molecular transport. The epidermis is a foundation of viable living cells being a transition to flat dead cells at its outer surface. The thin outermost layer of the epidermis is called the "stratum corneum" (SC) and it is most resistive to drug transport through the skin.
Below the epidermis there is a highly vascular inner skin layer, the dermis, that is characterized by a the large network of capillaries with high blood flow rates exceeding several times the metabolic requirements. The primary reason of such high perfusion rates in the dermis is to regulate body temperature. The dermis is also characterized by high collagen content, that provides the skin with its structural support.
Below the dermis there lies a thermally insulative fatty layer that also acts to conserve body heat. The skin, at most sites on the body, is perforated by appendageal pathways in the form of sweat glands and hair follicles.
The SC is composed of 15 20  layers of corneocytes, that is flat dead cell shells, which are interconnected by a lipid lamellar bilayer structure in a crystallinegel phase. Transport circumventing the barrier function of the SC is primarily associated to occur within the lamellar lipid structure of the SC (Bouwstra et al. [24] ; Madison [25] ). The thin SC corneocytes-lipid porous matrix (Fig.2) may be conceptualized as a brick-andmortar structure in which the highly impermeable corneocyte cells are represented by the brick and the slightly less impermeable intercellular lipid lamellar bilayers are represented by the mortar. Traditional drug deliveries often result in low efficacy and unintentional treatment of healthy tissues. Oral intake may result in drug denaturation in the gastro-intestinal track; drugs consisting of water soluble molecules may degrade before reaching intended locations of treatment. Injection of drugs into the circulatory system may result in lower selectivity level of the drug's region influence. Transdermal drug delivery is one method that allows localized delivery by transporting the drug directly through the skin to the desired target, as it is necessary, for example, in chemotherapy for drugs with a high toxicity.
Diffusion through brick-and-mortar structure
The representation of the SC matrix consisting of a symmetric brick-and-mortar model was introduced at first by Michaels et al. [10] in which the interstitial horizontal lengths between vertical spaces are all of the same length (Fig.3a) . A nonsymmetric variation of this model was introduced by Johnson et al. [14] ; this model describes more accurately the lateral diffusive path by using an offset, ω , that is defined as the ratio of long, rates into and out of the slice of the SC. Assuming that mass transport is restricted to the intercellular regions of the SC and following Kushner et al. [26] (see also [21] ) we may write the mass balance for the flowing permeant (drug solute) in the form
is the volume tortuosity factor, Taking into account that the real mortars (intercellular regions of the SC) are not regular let us introduce the so called "hindrance factor" (Walicka et al. [22] ) considering the irregularity of the mortar. Then Eq.(3.1) takes the form
where  is the hindrance factor.
Note that some mathematical considerations on the flows of Newtonian and non-Newtonian fluids through irregular capillary tubes and fissures one may find in [27, 28] . Consider now the diffusive mass flow rate of the drug delivered through the intercellular regions of the SC; according to Johnson et al. [14] it may be evaluated as (see also [21] 
or, after introducing the hindrance factor
where D is the diffusion coefficient,
is the flux tortuosity factor,
is the lateral diffusion path length. or in a more general form
where  is the velocity vector of the flow in the SC intercellular regions.
One of more general forms of this equation proposed by Picioreanu et al. [29] is as follows
where  is the coefficient of concentration and  is the source field of diffusion. 
The hindrance factor for human skin takes the values from the bracket . 0 8 1    .
Diffusion transport through the stratum corneum
Taking into account the fact that the flow in the brick-and-mortar fissure is a one-dimensional flow we may rewrite Eq.(3.6) in the following form 
C y 0 t C C y H t C C y t 0 C
where 1 C is the bulk concentration on the receiver side of the SC, 2 C is the bulk concentration on the donor side of the SC and 0 C is the initial concentration of the drug within the intercellular lipids of the SC. Note that y 0  corresponds to the outlet of the stratum corneum, whereas p y H  corresponds to the inlet of the stratum corneum. Introducing the non-dimensional magnitudes , , , ,
one may rewrite Eq.(4.1) as follows 
Note that for
therefore the diffusion distribution is linear.
Non-steady state diffusion through the SC
Let us rewrite Eq.(4.4) as follows 
Mass transport in non-steady state diffusion
The total amount of mass per unit area,
 
M t , delivered across the SC is given by a time integral have the drawback of being limited to systems having relatively simple geometries and boundary conditions. On the other hand, it seems that numerical methods are considerably more powerful and can be used to model more complex situations which more closely resemble those encountered experimentally [34] . More complex mathematical models that represent release into a biologically realistic membrane, e.g., taking into account the structural heterogeneity, and which incorporate diffusion in three-dimensions and any timedependent variation of the boundary conditions will have to employ advanced analytical methods of solutions. The aim of this paper was to improve the analytical method using a brick-and-mortar model, with uniform thickness of the mortar, describing the porosity of the stratum corneum. This aim was achieved by two steps dependent on:
 the introduction of two tortuosity factors,  the introduction of the hindrance factor. The influence of tortuosity on mass transport in porous media is well known but in drug diffusion transport tortuosity is rarely taken into account.
The hindrance factor represents the influence of variable thickness of the mortar fissure on the mass transport in porous medium. Introduction of this factor allows us to consider the fissure variability in a simple way.
It seems that the proposed methods of solution will contribute to a broader use of the analytical methods for a better understanding of drug diffusion transport through the skin. 
